APA (7th ed.) Citation

A, V., & B, C. (2024). Absence of cross-toxicity between MET inhibitors in a non-small-cell lung cancer with a MET exon 14 skipping mutation. Acta clinica Belgica, 79(2), 148. https://doi.org/10.1080/17843286.2024.2330137

Chicago Style (17th ed.) Citation

A, Vanderick, and Colinet B. "Absence of Cross-toxicity Between MET Inhibitors in a Non-small-cell Lung Cancer with a MET Exon 14 Skipping Mutation." Acta Clinica Belgica 79, no. 2 (2024): 148. https://doi.org/10.1080/17843286.2024.2330137.

MLA (9th ed.) Citation

A, Vanderick, and Colinet B. "Absence of Cross-toxicity Between MET Inhibitors in a Non-small-cell Lung Cancer with a MET Exon 14 Skipping Mutation." Acta Clinica Belgica, vol. 79, no. 2, 2024, p. 148, https://doi.org/10.1080/17843286.2024.2330137.